BiocSol SRL
3.1 FTEThe score of BiocSol shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BiocSol's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
BiocSol's financial analysis
- Solvency75.6%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BiocSol
BiocSol's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1003.683.546
- VAT number
- BE1003683546
- Peppol
- Registered · 0208:1003683546 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Dec 2023
- Registered office
- 1435 Mont-Saint-Guibert
- Size
- Micro · 3.1 FTE
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
BiocSol (SRL) has been based in Mont-Saint-Guibert since 2023, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 612,486 € and equity of €4.35m; its revenue is not published. With 3.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 75.6%, above the median of its sector (57.9%).
Companies similar to BiocSol
Companies in the same business, of comparable size and area, outside its group.
- Celyad Oncology Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €4.03m
- Aphea.Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.2m
- Dendrogenix Research and experimental development on natural sciences and engineering Liège · balance sheet €5.28m
- H2WIN Research and experimental development on natural sciences and engineering Nivelles · balance sheet €7.36m
- Novobiom Research and experimental development on natural sciences and engineering Liège · balance sheet €3.92m
- NemaTerra Research and experimental development on natural sciences and engineering Grobbendonk · balance sheet €2.02m
- BioWorks Wholesale of chemical products Westerlo · balance sheet €25.7m
- Spica Therapeutics Research and experimental development on natural sciences and engineering Antwerp · balance sheet €7.45m
Frequently asked questions about BiocSol
What is the revenue of BiocSol?
BiocSol files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BiocSol?
In Belgium, the VAT number is the company number prefixed with BE: BE1003683546 for BiocSol, if the company is VAT-registered. Its company number (CBE) is 1003.683.546.
Where is the registered office of BiocSol?
According to the CBE register, the registered office of BiocSol is in 1435 Mont-Saint-Guibert.
What is the equity of BiocSol?
At the close of the 2025 financial year, the equity of BiocSol amounts to 4,348,235 €, a solvency of 75.6% of total assets.
How many people work at BiocSol?
3.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BiocSol?
The register lists 11 active mandates at BiocSol. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BiocSol
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →